| Name | Glumetinib |
|---|
| Description | Glumetinib (SCC244) is a potent and highly selective c-Met kinase inhibitor with an IC50 of 0.42 nM. Glumetinib shows antitumor activity and a superior safety margin[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.42 nM (c-Met kinase)[1] |
| References |
| Molecular Formula | C21H17N9O2S |
|---|---|
| Molecular Weight | 459.48 |